MedPath

Affect of tranexamic acid on patient that have functional endoscopy surgery sinus (FESS)

Phase 3
Conditions
Sinusitis.
Chronic sinusitis
Registration Number
IRCT20221204056707N1
Lead Sponsor
Qazvin University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
45
Inclusion Criteria

Patients who have an indication for endoscopic surgery and do not have any underlying disease or blood problems, including coagulation problems

Exclusion Criteria

Elderly people who can't be able to tolerate anesthesia.
Patients who have an active or severe infection.
Patients who take immunosuppressive drugs or blood coagulation disruptors and immunocompromised patients.
Patients with underlying coagulation and blood problems and other patients with high surgical risk are excluded from this study.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effect of tranexamic acid on the volume of bleeding caused by endoscopic sinus surgery. Timepoint: At the end of surgery. Method of measurement: Measuring the volume of bleeding after surgery by suction and the number of gases used.;Determining the duration of bleeding under the influence of the drug. Timepoint: DURING THE SURGERY. Method of measurement: USE A STOPWATCH.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath